Sort
48,018 grants matching “immunotherapy”
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
$1,300,301Daniel J. Powell · University Of Pennsylvania · R01 · FY2025 · CA
Roswell Park Cancer Institute Center Support Grant
$1,300,294Donald L Trump · Roswell Park Cancer Institute Corp · P30 · FY2009 · CA
Dendritic Cell Biology and Therapy
$1,300,247University Of Pittsburgh At Pittsburgh · P01 · FY2004 · CA
Clinical Fellowship Training Program
$1,300,140Peter Pinto · Division Of Basic Sciences - Nci · ZIE · FY2022 · CA
Molecular Pharmacology Lab
$1,300,000Ethan Dmitrovsky · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA
Molecular Pharmacology Lab
$1,300,000Leonard Freedmand · Leidos Biomedical Research, Inc. · N01 · FY2019 · CA
Cell Prep Core
$1,299,944John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Cell Production Facility Core
$1,299,942Mark Dudley · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Cell Production Core Facility
$1,299,285Robert Somerville · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Surgery Branch Cell Prep Core
$1,299,285John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Mechanisms Underlying Clearance of the Persistently Infected CNS
$1,298,331Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS
Sirtuin -Dependent Regulation of Tuberculosis and HIV Interactions in Macrophages
$1,297,775Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2024 · AI
Validation of Serum Neurofilament Light Chain as a Prognostic and Monitoring Biomarker in Multiple Sclerosis
$1,297,756Peter A Calabresi · Johns Hopkins University · U01 · FY2020 · NS
Novel wearable rotating magnetic field therapy device targeting treatment of brain cancers
$1,296,385Ashok Gowda · Biotex, Inc. · R44 · FY2025 · CA
CO17 1A/GA733 ANTIGEN IN COLORECTAL CANCER THERAPY
$1,296,031Wistar Institute · P01 · FY2001 · CA
Epigenetic and immunologic aspects of neuroendocrine cancers
$1,295,687Nitin Roper · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Role of the microbiota in regulating the mononuclear phagocyte system
$1,295,242Romina Goldszmid · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,295,221Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma
$1,295,181Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir
$1,293,876Rafick-Pierre Sekaly · Emory University · P01 · FY2023 · AI
Innate inflammatory responses during pulmonary infections
$1,293,685Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Immunotherapy to deplete key Treg subsets in solid tumors
$1,293,505Peter David Suzdak · Sonoval Llc · R44 · FY2024 · CA
FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION
$1,293,012Prema Robinson · University Of Tx Md Anderson Can Ctr · N01 · FY2023 · CA
Development of Therapeutic Antibody for Traumatic Brain Injury
$1,292,737Mark L. Zeidel · Beth Israel Deaconess Medical Center · U01 · FY2021 · NS
Autonomic Disorders Programs Project
$1,292,690Phillip A Low · Mayo Clinic Rochester · P50 · FY2007 · NS